FDA NDC Directory · JSON-LD · Markdown

nelarabine

NDC 81927-375 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerShorla Oncology Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA214809
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNELARABINE (5 mg/mL)
Marketing started20250831
Package count1

External sources

Source: openFDA. Public-domain (CC0).